SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales moved up 30.11% to Rs. 10483.00 millions for the June 2023 quarter as compared to Rs. 8057.00 millions during the year-ago period.Good  Net Profit growth of 31.59% reported above the corresponding previous quarter figure of Rs. 3080.00 millions to Rs. 4053.00 millioins.Operating profit for the quarter ended June 2023 rose to 5183.00 millions as compared to 4126.00 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 10483.00 8057.00 30.11 10483.00 8057.00 30.11 23510.00 17678.00 32.99
Other Income 146.00 332.00 -56.02 146.00 332.00 -56.02 855.00 946.00 -9.62
PBIDT 5183.00 4126.00 25.62 5183.00 4126.00 25.62 9302.00 3076.00 202.41
Interest 32.00 27.00 18.52 32.00 27.00 18.52 86.00 133.00 -35.34
PBDT 5151.00 4099.00 25.66 5151.00 4099.00 25.66 9216.00 2943.00 213.15
Depreciation 399.00 369.00 8.13 399.00 369.00 8.13 1509.00 1384.00 9.03
PBT 4752.00 3730.00 27.40 4752.00 3730.00 27.40 7707.00 1559.00 394.36
TAX 699.00 650.00 7.54 699.00 650.00 7.54 1336.00 168.00 695.24
Deferred Tax -139.00 -10.00 1290.00 -139.00 -10.00 1290.00 5.00 -157.00 -103.18
PAT 4053.00 3080.00 31.59 4053.00 3080.00 31.59 6371.00 1391.00 358.02
Equity 358.00 365.00 -1.92 358.00 365.00 -1.92 365.00 365.00 0.00
PBIDTM(%) 49.44 51.21 -3.45 49.44 51.21 -3.45 39.57 17.40 127.39

Natco Pharma Share Price

1208.75 34.75 (2.96%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×